Carl F. Wittig
Philadelphia
Summary
Senior territory manager with over 8 years of experience in technical medical sales, clinical support, and therapy education. Proven track record of driving market expansion, establishing rapport with clinicians and patients, and building a successful team. Intensely driven to execute initiatives with consistency and excellence to form and uphold a reliable reputation amongst customers and our team.
Overview
9
9
years of professional experience
Work History
Territory Manager
ABBOTT BRAIN THERAPIES
07.2017 - Current
- Built territory from 2016 launch to $4 million market in 2025
- Promoted to Senior Territory Manager III – July 2025
- Managed and grew existing accounts- Pennsylvania Hospital, Jefferson Hospital for Neuroscience
- Opened new accounts- Geisinger Medical Center, Lehigh Valley Hospital, Cooper University Hospital, Hershey Medical Center
Clinical Specialist
ABBOTT BRAIN THERAPIES
01.2017 - Current
- Successfully establish and maintain referral steams and develop market for Deep Brain Stimulation (DBS) in multiple patient indications
- Educate physicians on best practices by leveraging relationships and utilizing corporate resources
- Initiate and market patient/physician outreach events
- Support clinical affairs, such as DBS programming sessions, implantation procedures, and MRI safety education
- Promoted from Intern to Clinical Specialist I – March 2019
- Promoted to Clinical Specialist II – January 2020
- Promoted to Territory Manager III -
Education
B.S. - Biological Basis of Behavior (Neuroscience)
UNIVERSITY OF PENNSYLVANIA
Philadelphia, PA01.2016
Skills
- Team collaboration and leadership
- Customer relationship management
- Multitasking and organization
- Business development
Accomplishments
President's Club team 2018
President's Club Territory Manager III of the Year 2022
LEADs Program Graduate
CORTEX Program Graduate
Research Experience
- Stem Cell Technician- Smilow Translational Research Laboratory
- Independently cultured, transfected, and cloned ESC’s (embryonic stem cells) for injection in mice blastocysts
- Successfully targeted stem cells with 80% efficiency using cutting edge CRISPR/Cas9 technology
- Assist colleagues with PCR, gel electrophoresis, and restriction enzyme digestion techniques to confirm genotypes
- Extract DNA via mini-prep and maxi-prep
Timeline
Territory Manager
ABBOTT BRAIN THERAPIES
07.2017 - Current
Clinical Specialist
ABBOTT BRAIN THERAPIES
01.2017 - Current
B.S. - Biological Basis of Behavior (Neuroscience)
UNIVERSITY OF PENNSYLVANIA